Financials Senzime AB

Stocks

Market Closed - Nasdaq Stockholm 13:00:00 2026-10-28 EDT			5-day change	1st Jan Change
2.805 ^SEK	-0.71%		-0.18%	-48.06%

10-19	Senzime: New studies show improved monitoring and potential cost savings	FW
10-17	Senzime AB Presents New Scientific Evidence For TetraGraph And Quantitative Neuromuscular Monitoring	CI

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	10.98	14.03	35.75	58.48	104	127.7	204	340.6
Change	-	27.81%	154.77%	63.55%	77.89%	22.76%	59.75%	66.96%
EBITDA ¹	-73.2	-118.4	-116.8	-97.83	-88.38	-49.5	-6.9	56.8
Change	-	-61.68%	1.32%	16.24%	9.65%	43.99%	86.06%	923.19%
EBIT ¹	-84.19	-133.9	-137.4	-124.1	-122.6	-74.2	-36.8	22.4
Change	-	-59.05%	-2.58%	9.69%	1.19%	39.47%	50.4%	160.87%
Interest Paid	-	-	-	-	-7.66	-	-	-
Earnings before Tax (EBT) ¹	-84.29	-134.4	-137.2	-122.8	-	-69.6	-36.8	-
Change	-	-59.4%	-2.08%	10.48%	-	-	47.13%	-
Net income ¹	-82.14	-132.7	-141	-118.7	-	-68.9	-36.8	-
Change	-	-61.55%	-6.25%	15.79%	-	-	46.59%	-
Announcement Date	2/17/22	2/1/23	2/15/24	2/17/25	2/18/26	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	7.288	8.462	9.154	10.85	12.12	14.92	17.41	14.03	23.5	25.7	26.48	28.35	23.23	24.67	30.2	47.1
Change	-	16.11%	8.18%	18.53%	11.71%	23.08%	16.69%	-19.37%	67.44%	9.35%	3.05%	7.07%	-18.05%	6.19%	22.41%	55.96%
EBITDA ¹	-26.46	-30.2	-25.48	-34.66	-23.91	-29.24	-26.52	-18.16	-20.84	-23.57	-19.4	-24.58	-20.2	-17.27	-10.2	-2.1
Change	-	-14.13%	15.64%	-36.02%	31%	-22.28%	9.31%	31.51%	-14.75%	-13.12%	17.72%	-26.72%	17.8%	14.53%	40.93%	79.41%
EBIT ¹	-31.42	-35.26	-30.59	-40.09	-29.34	-34.72	-32.05	-27.95	-26.9	-29.29	-25.42	-40.96	-25.89	-23.33	-16.6	-8.7
Change	-	-12.2%	13.23%	-31.03%	26.82%	-18.36%	7.69%	12.8%	3.76%	-8.9%	13.2%	-61.11%	36.81%	9.86%	28.86%	47.59%
Charge d'intérêts	-	-0.186	0.007	-	-	-	-	-	-8.844	-	-	-	-	-	-	-
Earnings before Tax (EBT)	-31.69	-35.26	-30.59	-39.62	-28.72	-34.26	-31.96	-27.84	-35.52	-34.16	-	-	-	-	-	-
Change	-	-11.27%	13.26%	-29.52%	27.51%	-19.29%	6.7%	12.91%	-27.6%	3.84%	-	-	-	-	-	-
Net income	-30.8	-34.36	-30.17	-38.81	-27.93	-33.41	-31.31	-26.08	-34.66	-34.35	-	-	-	-	-	-
Change	-	-11.56%	12.19%	-28.61%	28.03%	-19.63%	6.28%	16.73%	-32.93%	0.9%	-	-	-	-	-	-
Announcement Date	4/28/23	8/24/23	10/26/23	2/15/24	5/7/24	8/26/24	11/6/24	2/17/25	4/22/25	7/18/25	10/29/25	2/18/26	4/22/26	7/16/26	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt	-74.9	-13	-140	-78.3	-	-	-	-
Change	-	82.64%	-976.92%	44.07%	-	-	-	-
Announcement Date	2/17/22	2/1/23	2/15/24	2/17/25	2/18/26	-	-	-

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025
CAPEX ¹	0.192	1.171	0.979	0.95	2.362	2.744
Change	-	509.9%	-16.4%	-2.96%	148.63%	16.17%
Free Cash Flow (FCF) ¹	-18.12	-52.32	-68.31	-72.14	-72.93	-77.99
Change	-	-188.71%	-30.56%	-5.61%	-1.09%	-6.95%
Announcement Date	4/19/21	3/1/22	4/25/23	4/24/24	4/24/25	4/22/26

¹SEK in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-	-666.7%	-843.33%	-326.66%	-167.29%	-84.97%	-38.76%	-3.38%	16.68%
EBIT Margin (%)	-	-766.77%	-954.15%	-384.18%	-212.14%	-117.84%	-58.1%	-18.04%	6.58%
EBT Margin (%)	-	-767.66%	-957.37%	-383.62%	-209.96%	-	-54.5%	-18.04%	-
Net margin (%)	-	-748.11%	-945.56%	-394.35%	-203.03%	-	-53.95%	-18.04%	-
FCF margin (%)	-	-	-	-340.46%	-146.38%	-107.52%	-	-	-
FCF / Net Income (%)	-	-	-	86.34%	72.09%	-	-	-	-
Profitability
ROA	-15.14%	-24.53%	-30.45%	-22.11%	-19.07%	-18.8%	-	-	-
ROE	-27.8%	-43.02%	-64.34%	-42.09%	-32.92%	-42.26%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	2.66%	4.04%	2.64%	-	-	-
CAPEX / EBITDA (%)	-	-	-	-0.81%	-2.41%	-3.1%	-	-	-
CAPEX / FCF (%)	-	-	-	-0.78%	-2.76%	-2.45%	-	-	-
Items per share
Cash flow per share ¹	2.565	1.198	0.3725	1.262	0.758	0.4705	-	-	-
Change	-	-53.3%	-68.9%	238.62%	-39.92%	-37.92%	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	3.702	2.41	3.748	3.137	2.597	1.937	-	-	-
Change	-	-34.91%	55.54%	-16.3%	-17.2%	-25.43%	-	-	-
EPS ¹	-0.8442	-1.314	-1.992	-1.454	-0.9706	-0.9344	-	-	-
Change	-	-55.7%	-51.52%	27%	33.24%	3.73%	-	-	-
Nbr of stocks (in thousands)	62,493	62,493	69,884	119,706	132,475	157,215	-	-	-
Announcement Date	4/19/21	3/1/22	4/25/23	4/24/24	4/24/25	4/22/26	-	-	-